Clinical Trial Update: DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing DisCoVisc, DuoVisc, Healon5, and AmVisc Plus for cataract surgery, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• AmVisc Plus
• DisCoVisc
• DuoVisc
• Healon5 (ophthalmic viscosurgical device (hyaluronate-based; bacterially-derived))

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: COMPLETED | Results posted: 2009-06-16